Načítá se...
Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
OBJECTIVE: To characterize the therapeutic value of new drugs approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) and the association between these ratings and regulatory approval through expedited programs. DESIGN: Retrospective cohort study. SETTING: New drugs...
Uloženo v:
| Vydáno v: | BMJ |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537471/ https://ncbi.nlm.nih.gov/pubmed/33028575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.m3434 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|